ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biologics

Wacker acquires fermentation firm

by Rick Mullin
April 22, 2018 | APPEARED IN VOLUME 96, ISSUE 17

Germany’s Wacker Chemie says it will double its fermentation capacity with the acquisition of SynCo Bio Partners’ microbial products and vaccine facility in Amsterdam. The contract manufacturing site features fermentation lines with capacities of 270 L and 1,500 L as well as fill-and-finish capabilities for finished drugs. Wacker says it will maintain SynCo’s workforce of about 110 employees.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment